Every recall we track for Teva Pharmaceuticals USA, Inc — 83 in all — plus the complaints and injury reports the public filed about them.
Teva recalls Octreotide Acetate 30mg single-dose kits due to lack of sterility assurance from FDA inspection. Affected kits have specific NDC codes and lot numbers. No remedy provided in recall notice.
Teva recalls Claravis 10mg isotretinoin capsules with specific impurity levels. These capsules may contain unsafe levels of tretinoin, posing a health risk. Consumers should check their product details and follow official instructions.
Teva Pharmaceuticals recalls Clonidine Transdermal Systems due to use of unapproved raw materials. Affected units have specific NDC numbers and expiration dates. Consumers should contact Teva for details.
Teva Pharmaceuticals recalls Clonidine Transdermal System due to use of unapproved raw material. Affected units have specific NDC numbers and expiration dates. Consumers should contact the manufacturer for details.
Teva recalls Clonidine Transdermal System due to use of unapproved raw material. Affected units have specific NDC numbers and expiration dates. Consumers should contact Teva for details.
Teva Pharmaceuticals recalls Octreotide Acetate vials for gluteal use due to potential sterility issues from manufacturing quality failures. Affected lots expire through 2027.
Teva recalls Octreotide Acetate 10mg vials due to potential sterility issues from manufacturing quality problems. Affected lots manufactured in Greece for gluteal use.
Teva recalls Octreotide Acetate 20mg vials due to potential lack of sterility from manufacturing quality issues. Affected lots expire 9/31/2026 or 3/31/2027.
Teva recalls 100mg Metoprolol Succinate Extended-Release Tablets (NDC 45963-677-11) due to failed dissolution specifications. This may affect medication effectiveness. Contact Teva for details.
Teva recalls 200 mg Metoprolol Succinate Extended-Release Tablets (100 tablets) due to failed dissolution specifications. This may affect medication effectiveness. Contact Teva for details.
Teva recalls 25mg Metoprolol Succinate Extended-Release Tablets (100 and 1000 tablets) due to failed dissolution specifications. These tablets may not release medication properly, potentially affecting treatment effectiveness.
Teva recalls 50mg Metoprolol Succinate Extended-Release Tablets (100 and 1,000 tablets) due to failed dissolution specifications. These tablets may not release medication properly, potentially affecting treatment effectiveness.
Teva Pharmaceuticals recalls 30mg Isotretretinoin capsules due to superpotent and subpotent risks. Affected lots expire 02/2026 to 07/2027. No remedy specified in recall notice.
Teva Pharmaceuticals recalls 40mg Isotretretinoin capsules due to superpotent and subpotent risks. Affected lots have specific expiration dates and packaging identifiers.
Teva Pharmaceuticals recalls Testosterone Gel 1% (2.5g doses) due to defective container causing leakage. This may lead to product contamination. Affected units have specific lot numbers and expiration dates.
Teva Pharmaceuticals recalls specific amoxicillin-clavulanate oral suspension due to subpotent clavulanate potassium. This may result in ineffective treatment for bacterial infections. Consumers should contact the manufacturer for details.
Teva recalls 5mg Prazosin capsules with potential N-nitroso impurity exceeding safety limits. Consumers should stop using affected lots due to possible cancer risk.
Teva recalls 1 mg Prazosin capsules due to potential carcinogenic impurities. Affected lots have NDC 0093-4067-01 or 10. Stop using if you have these specific lots.
Teva Pharmaceuticals recalls 2mg Prazosin capsules with N-nitroso impurity levels above safety limits. Consumers should check NDC numbers and expiration dates for affected lots.
Teva recalls 100-count Metoclopramide 10mg tablets due to foreign tablets/capsules. Rx-only medication manufactured in Croatia. Check NDC 0093-2203-01 and lot 5420094.
Teva Pharmaceuticals recalls Granix (tbo-filgrastim) injection due to stability test failure. This may affect medication safety. Check product details to see if you have recalled items.
Teva Pharmaceuticals recalls 1.62% testosterone gel with alcohol 80% v/v due to superpotent drug risk. Affected units have specific NDC numbers and expiration dates. Consumers should contact Teva for details.
Teva Pharmaceuticals recalls 0.1mg fludrocortisone tablets due to impurities exceeding safety limits. Affected lots manufactured in Canada expire 2024. Consumers should check NDC 0555-0997-02 for details.
Teva recalls 40mg Isotretretinoin capsules due to potential stability issues affecting drug potency. Learn about affected lots and what to do.
Teva recalls Tri-Lo-Sprintec birth control tablets due to failed dissolution specifications. This may affect product effectiveness. Check NDC 0093-2140-62 and lot numbers for affected items.
Teva recalls Nortrel 7/7/7 tablets with discoloration (blue shades) mixed in with white tablets. Discarded tablets may be unsafe. Check NDC 0555-9012-58 and lot 100040731 for affected units.
Teva recalls Nortrel 0.5/35 tablets with discolored (blue) tablets mixed in. Affected units have specific NDC and lot numbers. Stop using if you see discoloration.
Teva Pharmaceuticals recalls 9mg Budesonide Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Teva Pharmaceuticals recalls 1.62% testosterone gel with OOS viscosity. This may affect product stability. Consumers should check NDC 0591-2926-30 and lot number 100029472.
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets CII 100mcg due to incorrect or missing package inserts. This may lead to improper use. Consumers should contact the manufacturer for details.
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets (800mcg) due to missing or incorrect package inserts. This may affect safe use of prescription pain medication. Consumers should check product details and contact Teva for guidance.
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets (200mcg) due to missing package inserts. This could lead to incorrect use. Consumers should contact the manufacturer for details.
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets CII 400mcg due to missing or incorrect package inserts. This may affect safe use of the medication. Consumers should contact the manufacturer for details.
Teva Pharmaceuticals recalls Fentanyl Buccal Tablets (600mcg) due to missing or incorrect package inserts. This could lead to improper use. Affected units include specific lots from Mayne Pharma.
Teva recalls Montelukast Sodium Oral Granules 4mg (30-pack) due to failed impurities. This may pose health risks. Contact Teva for details.
Teva recalls Clear Eyes allergy eye drops due to impurities found in stability testing. Affected lots expire May 2023 through February 2024. No remedy specified in recall notice.
Teva recalls 1000mg Metformin XR tablets with NDMA levels above safe limits. This may pose health risks. Check your bottle for lot number 1410946A.
Teva Pharmaceuticals recalls 100-count amphetamine tablets labeled 15mg but containing 20mg tablets. This label error may lead to incorrect dosing. Consumers should check their bottles for the specific lot number.
Teva recalls Neomycin Sulfate 500mg tablets due to teflon contamination in the active ingredient. Affected lots expire 10/2024. Stop using immediately.
Teva Pharmaceuticals recalls Azacitidine 100mg/vial lyophilized powder (Rx only) manufactured in Romania due to subpotent drug results from stability testing. This may affect medication effectiveness.
Teva Pharmaceuticals recalls Matzim LA 240mg extended-release tablets due to failed dissolution specifications. This may affect medication effectiveness. Check your product details to see if you need to take action.
Teva Pharmaceuticals recalls Testosterone Gel 1% (25mg testosterone/2.5g) due to out of specification assay results from stability testing. Affected units have specific NDC and lot numbers.
Teva Pharmaceuticals recalls Alprostadil Injection USP 500 mcg/mL vials due to impurities found in stability testing. This medication may cause serious injury if used improperly.
Teva recalls 0.5mg Anagrelide Capsules due to failed dissolution testing. This may affect medication effectiveness. Check NDC 0172-5241-60 and lot # GD01090.
Teva Pharmaceuticals recalls Lidocaine 2.5% and Prilocaine 2.5% Cream due to cGMP deviations. Products sold in 5g and 30g tubes with specific lot numbers and expiration dates.
Teva recalls IDArubicin Hydrochloride Injection 5mL vials due to silica and iron oxide particles. This may cause serious complications if injected. Contact Teva for details.
